MLEC Moolec Science SA: Price-to-Projected Revenue Ratio

Moolec Science SA is a leader in molecular farming with patent protection for its soy and pea platforms. The company's modeled P/S ratio demonstrates the efficiency of synthesizing animal proteins in plant seeds without bioreactors, where 0.60 represents the current metric level. The development of sustainable protein products in an active growth phase opens broad prospects for the issuer within the food industry.

This indicator assesses the asset's market value relative to expected sales, allowing for a determination of the premium paid for future cash flows. By analyzing the forward price-to-sales ratio, an investor can evaluate the capitalization of Moolec Science (MLEC) patents for protein synthesis in plants, where sharp fluctuations on the chart signal a reassessment of licensing model risks and the potential for long-term passive income.